NDC 70504-0053-2 Hepagam B

  1. Labeler Index
  2. Aptevo Biotherapeutics Llc
  3. 70504-0053
  4. NDC Package Code: 70504-0053-2 Hepagam B

NDC Package Code 70504-0053-2

The NDC Code 70504-0053-2 is assigned to a package of 1 vial in 1 carton > 1 ml in 1 vial (70504-0053-1) of Hepagam B, labeled by Aptevo Biotherapeutics Llc. The product's dosage form is and is administered via form.This product is billed per "ML" milliliter and contains an estimated amount of 1 billable units per package.

Field Name Field Value
NDC Code 70504-0053-2
Package Description 1 VIAL in 1 CARTON > 1 mL in 1 VIAL (70504-0053-1)
Product Code 70504-0053
Proprietary Name Hepagam B What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Drug Uses This medication is used to prevent a certain serious virus infection (hepatitis B) in people who have been exposed to this virus under certain conditions (such as direct contact with blood or body fluids containing this virus). Certain brands of this medication may also be given after a liver transplant to prevent return of hepatitis B infection in people with previous infection. Ask your doctor or pharmacist if you have questions about your particular brand. This medication is made from healthy human blood that has high levels of certain defensive substances (antibodies) that help fight hepatitis B.
11-Digit NDC Billing Format 70504005302 NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
Billing Unit ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Estimated Billable Units per Package 1 ML
RxNorm Crosswalk
  • RxCUI: 1658125
  • RxCUI: 1658147
  • RxCUI: 1658159
  • RxCUI: 1658423
    • Labeler Name Aptevo Biotherapeutics Llc
    Sample Package No Sample Package?
    This field Indicates whether this package is a sample packaging or not.
    Start Marketing Date 07-01-2016 What is the Start Marketing Date?
    This is the date that the labeler indicates was the start of its marketing of the drug product.
    Listing Expiration Date 12-31-2021 What is the Listing Expiration Date?
    This is the date when the listing record will expire if not updated or certified by the product labeler.
    Exclude Flag I What is the NDC Exclude Flag?
    This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".
    This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

    NDC Code Structure

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 70504-0053-2 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    70504005302J1573Hepagam b intravenous, inj0.5 ML1122
    70504005302J1571Hepagam b im injection0.5 ML1122

    * Please review the disclaimer below.